Prior studies have shown that PLOD2 is expressed at higher levels in squamous cell carcinoma compared to high-grade squamous intraepithelial lesions and normal cervical cells (64), primarily due to its role in catalyzing the hydroxylation of lysine residues in collagen molecules (65, 66). The gene discussed is PLOD2; the disease is squamous cell intraepithelial neoplasia.